CCBTX | FBBTX | CCBTX / FBBTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 11 years | - |
Gain YTD | 9.277 | 10.025 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.13B | 5.13B | 100% |
Annual Yield % from dividends | 1.81 | 2.89 | 63% |
Returns for 1 year | 15.96 | 17.17 | 93% |
Returns for 3 years | 1.98 | 4.57 | 43% |
Returns for 5 years | 15.43 | 19.53 | 79% |
Returns for 10 years | 22.77 | 30.34 | 75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NSBRX | 65.21 | 0.01 | +0.02% |
Nuveen Dividend Growth I | |||
ETAHX | 36.47 | -0.17 | -0.46% |
Eventide Healthcare & Life Sciences A | |||
MYINX | 8.02 | -0.05 | -0.62% |
NYLI WMC International Rsrch Eq Inv Cl | |||
TVRRX | 80.98 | -0.57 | -0.70% |
Thornburg Small/Mid Cap Core R5 | |||
MVEIX | 11.58 | -0.09 | -0.77% |
Monteagle Select Value I |